Literature DB >> 1922387

Phosphorylation of c-jun mediated by MAP kinases.

B J Pulverer1, J M Kyriakis, J Avruch, E Nikolakaki, J R Woodgett.   

Abstract

The proto-oncogene c-jun is a component of the AP-1 transcription factor family involved in the mediation of nuclear events elicited by extracellular stimuli. The c-jun protein is negatively regulated by phosphorylation of residues near the carboxy terminus which are dephosphorylated in response to phorbol esters. Here we identify two serine residues in the amino terminal A1 transactivation domain which are phosphorylated in response to a variety of mitogens, phorbol esters and activated ras. We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun. The MAP kinase enzymes pp54 and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation. MAP kinase activation of c-jun may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922387     DOI: 10.1038/353670a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  388 in total

1.  Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.

Authors:  S Kraus; R Seger; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress.

Authors:  M Avkiran; A K Snabaitis
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

Review 3.  Cardiac signal transduction.

Authors:  K H Lee; R J Hajjar; T Matsui; G Choukroun; T L Force; A Rosenzweig
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

4.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  The role of proofreading in signal transduction specificity.

Authors:  Peter S Swain; Eric D Siggia
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

6.  Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.

Authors:  E T Coffey; V Hongisto; M Dickens; R J Davis; M J Courtney
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

7.  Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.

Authors:  Aimee E Vozenilek; Aaron R Navratil; Jonette M Green; David T Coleman; Cassidy M R Blackburn; Alexandra C Finney; Brenna H Pearson; Roman Chrast; Brian N Finck; Ronald L Klein; A Wayne Orr; Matthew D Woolard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-07       Impact factor: 8.311

8.  Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein.

Authors:  Angela Clerk; Timothy J Kemp; Joanne G Harrison; Anthony J Mullen; Paul J R Barton; Peter H Sugden
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.

Authors:  Carolyn Wiltshire; Masato Matsushita; Satoshi Tsukada; David A F Gillespie; Gerhard H W May
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 10.  Molecular mechanisms of nitrogen dioxide induced epithelial injury in the lung.

Authors:  Rebecca L Persinger; Matthew E Poynter; Karna Ckless; Yvonne M W Janssen-Heininger
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.